Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells - Merz, Patrick; Ballikaya, Seda; Auffarth, Gerd U.; Schmack, Ingo (BMC ophthalmology, 2018)
Gesehen am 21.12.2018